197 related articles for article (PubMed ID: 6373343)
1. Long term almitrine bismesylate treatment in patients with chronic bronchitis and emphysema: a multicentre double-blind placebo controlled study.
Arnaud F; Bertrand A; Charpin J; Chretien J; Decroix G; Guerrin F; Kalb JC; Lissac J; Michel FB; Morere P
Eur J Respir Dis Suppl; 1983; 126():323-36. PubMed ID: 6373343
[No Abstract] [Full Text] [Related]
2. Acute and chronic effects of low dose almitrine bismesylate in the treatment of chronic bronchitis and emphysema.
Winkelmann BR; Leinberger H; Hertrich FF; Rapp W; Dieterich HA; Ansquer JC
Eur J Med; 1992 Dec; 1(8):469-81. PubMed ID: 1341206
[TBL] [Abstract][Full Text] [Related]
3. Nocturnal desaturation in patients with bronchitis and emphysema.
Bonsignore G
Eur J Respir Dis Suppl; 1983; 126():291-4. PubMed ID: 6586443
[No Abstract] [Full Text] [Related]
4. Almitrine improves oxygenation when both awake and asleep in patients with hypoxia and carbon dioxide retention caused by chronic bronchitis and emphysema.
Connaughton JJ; Douglas NJ; Morgan AD; Shapiro CM; Critchley JA; Pauly N; Flenley DC
Am Rev Respir Dis; 1985 Aug; 132(2):206-10. PubMed ID: 4026044
[TBL] [Abstract][Full Text] [Related]
5. Vectarion International Multicentre Study (VIMS): a long term double blind placebo controlled trial in COLD patients.
Sadoul P
Eur J Respir Dis Suppl; 1983; 126():357-61. PubMed ID: 6373344
[TBL] [Abstract][Full Text] [Related]
6. Long term studies on almitrine bismesylate in COPD patients.
Bourgouin-Karaouni D; Mercier J; Prefaut C
Eur J Respir Dis Suppl; 1986; 146():695-701. PubMed ID: 3096767
[TBL] [Abstract][Full Text] [Related]
7. [Long-term (6 months) treatment of chronic bronchitis with respiratory insufficiency using almitrine dimesylate. Double-blind study versus placebo].
Paramelle B; Joubert C; Dain MP
Presse Med; 1984 Oct; 13(34):2094-8. PubMed ID: 6149538
[TBL] [Abstract][Full Text] [Related]
8. Effects of almitrine bismesylate 100 mg daily for four weeks on respiratory regulation in patients with chronic bronchitis.
Stanley NN
Eur J Respir Dis Suppl; 1986; 146():635-9. PubMed ID: 3096763
[TBL] [Abstract][Full Text] [Related]
9. The assessment of almitrine bismesylate in the long-term treatment of chronic obstructive bronchitis.
Marsac J
Eur J Respir Dis Suppl; 1986; 146():685-93. PubMed ID: 3096766
[No Abstract] [Full Text] [Related]
10. The acute effect of a single oral dose of 200 mg almitrine on gas exchange in patients with chronic obstructive bronchitis and emphysema, bronchial asthma and lung fibrosis.
Magnussen H; Radenbach D; Kiwull-Schöne H
Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():211s-214s. PubMed ID: 3690032
[TBL] [Abstract][Full Text] [Related]
11. [Almitrine bismesylate treatment in chronic respiratory insufficiency].
González Ruiz JM; Villamor León J; García-Satué JL; Sánchez Agudo L; Calatrava JM; Carreras J
Rev Clin Esp; 1994 Dec; 194(12):1007-12. PubMed ID: 7863045
[TBL] [Abstract][Full Text] [Related]
12. [Value of almitrine dimesylate in the long-term treatment of chronic obstructive bronchitis].
Seignalet C; Miech G
Rev Med Interne; 1985; 6 Spec No():21-9. PubMed ID: 3938854
[No Abstract] [Full Text] [Related]
13. [Long-term treatment of chronic bronchitis and chronic emphysematous bronchitis with a sulfonamide with long half-life].
Müller M; Ulmer WT
Arzneimittelforschung; 1967 Jul; 17(7):872-4. PubMed ID: 4885151
[No Abstract] [Full Text] [Related]
14. Double-blind placebo controlled clinical trial of almitrine bismesylate in patients with chronic respiratory insufficiency.
Bakran I; Vrhovac B; Stangl B; Tabori D; Ivicevic A; Todic V; Kandare F
Eur J Clin Pharmacol; 1990; 38(3):249-53. PubMed ID: 2187700
[TBL] [Abstract][Full Text] [Related]
15. [Pulmonary hemodynamic monitoring in chronic respiratory insufficiency treated with almitrine bismesilate for 4 months in a double-blind study].
Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J; Prefaut C
Rev Mal Respir; 1984; 1(4):245-50. PubMed ID: 6505362
[TBL] [Abstract][Full Text] [Related]
16. [Almitrine per os in the therapy of chronic obstructive bronchopneumopathies].
Seignalet C; Préfaut C; Gonzales C; Michel FB
Rev Fr Mal Respir; 1980; 8(6):627-33. PubMed ID: 7027375
[TBL] [Abstract][Full Text] [Related]
17. Peripheral nerve function in patients with chronic bronchitis receiving almitrine or placebo.
Allen MB; Prowse K
Thorax; 1989 Apr; 44(4):292-7. PubMed ID: 2548299
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the effects of almitrine or oxygen breathing on pulmonary arterial pressure and right ventricular ejection fraction in hypoxic chronic bronchitis and emphysema.
MacNee W; Connaughton JJ; Rhind GB; Hayhurst MD; Douglas NJ; Muir AL; Flenley DC
Am Rev Respir Dis; 1986 Sep; 134(3):559-65. PubMed ID: 3752712
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic importance and tolerance of coated 50 mg Vectarion tablets (almitrine bismesylate) at a dosage of 100 mg/day. Study of blood gas, clinical and biological results after a year of long-term treatment].
Ansquer JC; Bertrand A; Blaive B; Charpin J; Chrétien J; Decroix G; Kalb JC; Lissac J; Michel FB; Morère P
Rev Mal Respir; 1985; 2 Suppl 1():S61-7. PubMed ID: 2870549
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of almitrine bismesylate on oxygenation during wakefulness and sleep in chronic obstructive pulmonary disease.
Gothe B; Cherniack NS; Bachand RT; Szalkowski MB; Bianco KA
Am J Med; 1988 Mar; 84(3 Pt 1):436-44. PubMed ID: 2894764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
